MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: Novo-appointed director steps down from ConvaTec board

ALN

ConvaTec Group PLC - Reading, England-based medical products and technologies company - Non-Executive Director Sten Scheibye steps down from the board with immediate effect, having served since 2018. Scheibye was nominated by Novo Holdings AS, which as a significant shareholder in ConvaTec was entitled to nominate one non-executive director to the board. The companies agree to end this arrangement, but ConvaTec says Novo ‘remains an important shareholder’.

Novo Holdings comments: ‘Given the increasing momentum in Convatec’s growth and margin trajectory and the high regard and confidence we have in management, we no longer feel a need to occupy a board position at the company. As shareholders, we are very excited by the opportunity we see for further value creation by the company.’

Novo Holdings is the controlling shareholder of Danish pharmaceutical firm Novo Nordisk AS and biotech firm Novozymes. It also invests and manages the assets and wealth of the Novo Nordisk Foundation.

Novo Nordisk is Europe’s most valuable company, with a market capitalisation of kr2.28 trillion, about $327.5 billion.

Current ConvaTec stock price: 220.40 pence, down 4.5% on Friday morning

12-month change: down 2.4%

Copyright 2023 Alliance News Ltd. All Rights Reserved.